Neuronetics, Inc.
$1.73 -$0.15 (-7.98%) 1D After hoursKey Metrics
The Story So Far
LAST 6 MONTHS PRIMARY SOURCES ONLY-
Jul 20
A material event was filed (Form 8-K).
8-K - Neuronetics, Inc. (0001227636) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 20
The stock moved +24.7% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Jul 20 -
Jul 16
Money rotated out of high-beta cohorts market-wide.
High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.
RECEIPT: ROTATION GAUGE, LIVE -
May 28
The stock moved +26.2% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, May 28 -
May 18
From its Jan 29 high, the share price fell 46%.
Peak close $2.20 on Jan 29; trough close $1.18 on May 18. The drawdown is the fact — the chapters around it are the context.
RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
The story updates itself as events post · The wolf reports; you decide
Snapshot
About Neuronetics, Inc.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
Wolf Grade COMING SOON
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.